Zimmer Holdings Inc (ZMH)

ZMH (NYSE:Health Services)
$101.46
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | ZMH Avg Daily Volume: 1,175,300
Last Update: 09/29/14 - 4:00 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $101.46
52 Week Range: $80.55 - $108.33
Oustanding Shares: 168,916,897
Market Cap: 17,172,091,749
6-Month Chart
TheStreet Ratings Grade for ZMH
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 13 13 12
Moderate Buy 0 1 1 1
Hold 7 7 8 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.70 1.71 1.77 1.91
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
ZMH Sector Avg. S&P 500
0.00 22.20 28.46
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 3.40 0.10 0.03
Net Income 0.80 0.27 0.08
EPS 3.30 0.51 0.14
Earnings for ZMH:
EBITDA 1.61B
Revenue 4.62B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.31 $1.74 $6.05 $6.57
Number of Analysts 14 13 19 18
High Estimate $1.33 $1.78 $6.29 $7.79
Low Estimate $1.30 $1.72 $6.00 $6.27
Prior Year $1.25 $1.66 $5.75 $6.05
Growth Rate (Year over Year) 4.40% 5.00% 5.27% 8.58%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Invest in Longevity Real Money Pro($)

Consider this unsexy but good value play in healthcare. 
 Hepatitis C therapies are the pacesetters.
Bullish
Aug 18, 2014 | 7:22 AM EDT
ZMH was upgraded to Outperform, William Blair said. Recent pullback has created a buying opportunity, as the Biomet deal should be accr...
It's time to start buying selectively during the pullback.
Bullish
Jul 28, 2014 | 7:44 AM EDT
ZMH was upgraded from Perform to Outperform, Oppenheimer said. $118 price target. Biomet deal should add to earnings, beginning in 2015...
Spice up your portfolio with some takeover bait.
Bullish
May 14, 2014 | 7:27 AM EDT
ZMH was upgraded from Hold to Strong Buy, Needham said. BMET purchase should add to earnings and both companies can gain market share i...

Slow-and-Steady Winners Real Money Pro($)

Six stocks poised to deliver favorable returns for the balance of the year.
Suddenly these companies have gone from embarrassing to, yes, embarrassingly rich.
Update
Apr 21, 2014 | 7:53 AM EDT
ZMH was upgraded to Buy from Hold, Cantor Fitzgerald said. Valuation call with improving volume and mix trends. $105 price target. ...

Columnist Conversations

Kass:
Big win on short side today with F and GM on the lower Ford guidance. My short theme continues to be "Peak Aut...
The 16th annual Geneva Report, Deleveraging, What Deleveraging? is available below. http://www.voxeu.org/cont...
$66 following the print...great rec last week into earnings and earlier posts in the $50s.
Equities start out the trading week on a down note as Hong Kong comes out of the blue to be added to the grab ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.